Navigation Links
Drug Used to Prevent Prostate Cancer Won't Lower Quality of Life
Date:9/12/2012

WEDNESDAY, Sept. 12 (HealthDay News) -- Proscar (finasteride), a drug used to treat an enlarged prostate, does not reduce the quality of life of men who use it for a prolonged period of time, found a new study funded by the U.S. National Cancer Institute.

Published Sept. 12 in the Journal of the National Cancer Institute, the research involved men aged 55 and older enrolled in a seven-year randomized clinical trial looking at the drug's possible use for prostate cancer prevention.

Researchers from the Fred Hutchinson Cancer Research Center in Seattle, led by Carol Moinpour of the public health sciences division, examined three areas of patients' quality of life. Proscar did not significantly affect the men's physical functioning, mental health or vitality, according to a journal news release.

Participants completed questionnaires three months before the study and six months after the study began. They were also surveyed once a year for the next seven years.

Men who smoked or had other health conditions saw more pronounced effects on their quality of life, particularly their physical functioning. The researchers said patients' lifestyles and other health problems should be considered when they are given treatments to prevent disease.

Other factors in the varied group of men made more of a difference than the drug, and "particularly diabetes and current smoking status, had a greater clinically relevant impact on the physical functioning score then did finasteride treatment," the authors wrote.

"Our findings reinforce the need to consider individual differences in age, time on study, smoking status, and [other medical conditions] when evaluating the effect of different preventive interventions on health-related quality of life," they concluded.

More information

The U.S. National Institutes of Health has more about Proscar.

-- Mary Elizabeth Dallas

SOURCE: Journal of the National Cancer Institute, news release, Sept. 12, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. More Evidence That Truvada Can Help Prevent HIV
2. A carefully scheduled high-fat diet resets metabolism and prevents obesity
3. New grant awards aim to prevent autoimmune diseases
4. Vanderbilt study looks at benefits of progestogens to prevent early childbirth
5. Mayo Clinic suicide prevention expert outlines new steps to tackle military suicide
6. Suicide prevention, telemedicine among topics at Mayo Clinic Transform 2012
7. Stem-cell-protecting drug could prevent the harmful side effects of radiation therapy
8. Report: Strategies to prevent noise-induced hearing loss, tinnitus in soldiers
9. Ginkgo Wont Prevent Alzheimers, Study Finds
10. Treated Vaginal Ring Prevents HIV in Monkeys
11. Magic carpet could help prevent falls
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Used to Prevent Prostate Cancer Won't Lower Quality of Life
(Date:1/20/2017)... ... ... “Mary Magdalene: Grace is Greater than Sin”: a unique and memorable ... firsthand. “Mary Magdalene: Grace is Greater than Sin” is the creation of published author, ... countless women who had little knowledge of the female characters portrayed in the Holy ...
(Date:1/20/2017)... Farmville, NC (PRWEB) , ... January 20, 2017 ... ... the vPEP ® Oscillating Positive Expiratory Pressure (OPEP) device, was featured in ... article by Doug Pursley, MEd, RRT-ACCS, FAARC, “Analysis of Three Oscillating Positive ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Land of More and ... the issue of world hunger, and shares the simple and achievable answer. “The Land ... and member of the Fairview Missionary Church in Angola, Indiana where he works with ...
(Date:1/19/2017)... Angeles (PRWEB) , ... January 19, 2017 , ... Next ... Act will be repealed by Congressional political games that circumvent health needs of over ... Stand Rally” capture the human anxieties and needs government public servants were suppose to ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... innovators, engineers, and scientists from around the world, announces the launch of its ... quick and easy portal to research breakthroughs and trending news, vital information on ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Shire plc (LSE: SHP, NASDAQ: ... Drug Administration (FDA) has acknowledged receipt of the Class ... SHP465, a long-acting, triple-bead, mixed amphetamine salts formulation. SHP465 ... Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is expected to provide ... designated Prescription Drug User Fee Act (PDUFA) action date. ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
(Date:1/19/2017)... NEW YORK , January 18, 2017 , , ... rd distribution agreement, following similar agreements ...   , Wound care is $2 5 ...   , E-QURE Corp. (OTCQB: EQUR), a leader in medical devices ... agreement with Tech - Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia ...
Breaking Medicine Technology: